ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth-0.12%

64.36%
1 Year Return
Equity
Sectoral/Thematic
3.0star
6M
1Y
All

Fund Details

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth

RiskHigh
Min SIP Amount₹100
Expense Ratio1.45%
NAV16.37 (23 Oct 2020)
Fund Started15 Jun 2018
Fund Size1,988 Cr

Returns

1Y
3Y*
5Y*
Since inception*
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth
64.4%
NA
NA
24.1%
Category Average
58.6%
15.8%
4.9%
-
Rank within category
3
NA
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    Estimated Value
    as per Historical Returns
    0
    with 64.4% annual returns

    Comparison

    Data not available
    Pros
    1. 1Y Returns are higher than the category average returns
    Cons
    1. Age is less than 3 years
    2. Risk-adjusted returns are lower compared to the category

    Top Holdings

    NameSectorInstrument% Assets
    Cipla Ltd.HealthcareEquity9.6%
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity9.3%
    Alkem Laboratories Ltd.HealthcareEquity5.4%
    Dr. Reddy's Laboratories Ltd.HealthcareEquity5.2%
    Divi's Laboratories Ltd.HealthcareEquity4.6%
    Lupin Ltd.HealthcareEquity4.5%
    Tata Chemicals Ltd.ChemicalsEquity4.3%
    Ipca Laboratories Ltd.HealthcareEquity4.0%
    Dr. Reddy's Laboratories Ltd.HealthcareFutures3.7%
    Sanofi India Ltd.HealthcareEquity3.3%
    See All

    Fund Managers

    addIhab Dalwai
    Education
    Mr. Dalwai is a Chartered Accountant.
    Experience
    He is associated with ICICI Prudential AMC since April 2011.
    Funds Managed
    addPriyanka Khandelwal
    Education
    Ms. Khandelwal is Chartered Accountant and Company Secretary
    Experience
    She has been Working with ICICI Prudential Mutual Fund Since October 2014.
    Funds Managed
    addDharmesh Kakkad
    Education
    Mr. kakkad is B.com., CA & CFA.
    Experience
    Mr. Kakkad is Manager in ICICI Prudential Mutual Fund since 2009.
    Funds Managed

    ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth Details

    ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 15 Jun 2018. Ihab Dalwai, Priyanka Khandelwal is the Current Fund Manager of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,988 Cr and the Latest NAV as of 23 Oct 2020 is ₹16.37.

    The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth is rated High risk. Minimum SIP Investment is set to 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 15 days.

    Investment Objective

    The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

    Tax Implications

    Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

    Scheme Information Document(SID)

    ₹5000
    Min for First Investment
    ₹1000
    Min for Second Investment
    Exit load of 1% if redeemed within 15 days.
    Exit Load

    Compare Funds

    ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Growth
    VS
    search

    About ICICI Prudential Mutual Fund

    Address
    One BKC, A-Wing, 13th Floor, Bandra Kurla Complex Mumbai 400051
    Phone
    022-26525000
    Launch Date
    13 Oct 1993
    ICICI Prudential Mutual Fund
    Asset Management Company
    Custodian
    NA
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Similar Funds
    Data not available